Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Account Payables: 2023-2025

Historic Change in Account Payables for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$546,000.

  • Camp4 Therapeutics' Change in Account Payables fell 150.42% to -$546,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 262.13%. This contributed to the annual value of $168,000 for FY2024, which is 115.07% up from last year.
  • Camp4 Therapeutics' Change in Account Payables amounted to -$546,000 in Q3 2025, which was down 187.37% from -$190,000 recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Change in Account Payables registered a high of $1.1 million during Q3 2024, and its lowest value of -$1.0 million during Q2 2024.
  • Its 3-year average for Change in Account Payables is -$67,875, with a median of -$170,000 in 2023.
  • Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 470.67% in 2024, then surged by 81.80% in 2025.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' Change in Account Payables stood at -$150,000 in 2023, then tumbled by 470.67% to -$856,000 in 2024, then plummeted by 150.42% to -$546,000 in 2025.
  • Its last three reported values are -$546,000 in Q3 2025, -$190,000 for Q2 2025, and $175,000 during Q1 2025.